Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has updated its date references to February 2025, indicating a shift in the timeline of information presented. Additionally, previous notices about service performance and specific past dates have been removed.SummaryDifference2%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.SummaryDifference0.2%
- Check94 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.